European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Background

Withdrawals of Application - Medicinal Products for Human Use
Medicinal products for which an initial marketing-authorisation application or extension application was withdrawn

Withdrawal announced Medicinal product INN
15/05/2009 Lunivia INN: eszopiclone
23/04/2009 Clopidogrel Teva Pharma INN: clopidogrel hydrobromide
19/03/2009 Ixempra INN: ixabepilone
16/03/2009 Cylatron INN: peginterferon alfa-2b
17/02/2009 Vorinostat MSD INN: vorinostat
19/12/2008 Advexin INN: contusugene ladenovec
04/12/2008 Theraloc INN: nimotuzumab
18/11/2008 Vekacia INN: ciclosporin
24/10/2008 Vibativ INN: telavancin
15/10/2008 Ellefore INN: desvenlafaxine
26/09/2008 Lacosamide Pain INN: lacosamide
25/09/2008 Ramelteon INN: ramelteon
10/09/2008 Exulett INN: dalbavancin
05/08/2008 Orplatna INN: satraplatin
24/07/2008 Diractin INN: ketoprofen
19/06/2008 Spanidin INN: gusperimus
16/06/2008 Aflunov Common name: Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
04/06/2008 Lenalidomide Celgene Europe INN: lenalidomide
28/05/2008 Aquilda INN: satavaptan
27/05/2008 DuoCover INN: clopidogrel/acetylsalicylic acid
27/05/2008 DuoPlavin INN: clopidogrel/acetylsalicylic acid
23/05/2008 orBec INN: beclomethasone diproprionate
17/03/2008 Kiacta INN: eprodisate disodium
12/03/2008 Pristiqs INN: desvenlafaxine
16/01/2008 Insulin Human Rapid Marvel INN: human insulin
16/01/2008 Insulin Human Long Marvel INN: human insulin
16/01/2008 Insulin Human 30/70 Mix Marvel INN: human insulin
14/12/2007 Sinerem INN: superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate
16/11/2007 Gastromotal INN:1-13C-caprylic acid
26/07/2007 Garenoxacin mesylate INN: garenoxacin
24/07/2007 Cerepro INN: adenovirus-mediated Herpes simplex virus-thymidine kinase gene
23/07/2007 Retisert INN: fluocinolone acetonide
21/05/2007 Voraxaze INN: glucarpidase
25/04/2007 Vitragan INN: hyaluronidase (ovine)
26/03/2007 Iplex INN: mecasermin rinfabate
15/03/2007 Arxxant INN: ruboxistaurin
08/12/2006 Synordia INN: fenofibrate/metformin hydrochloride
13/10/2006 Riquent INN: abetimus
08/09/2006 Multaq INN: dronedarone
27/06/2006 Scintimun INN: besilesomab
08/06/2006 Surfaxin INN: sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol, palmitic acid
28/03/2006 Retaane INN: anecortave
28/02/2006 Ximelagatran AstraZeneca 36mg film coated tablets INN:ximelagatran
27/01/2006 Orathecin INN: rubitecan
************
Medicinal products for which an application for extension of indication was withdrawn
Withdrawal announced Medicinal product INN
09/03/2009 Stalevo INN: levodopa/carbidopa/entacapone
17/12/2008 Invega INN: paliperidone
17/11/2008 Taxotere INN: docetaxel
17/11/2008 Docetaxel Winthrop INN: docetaxel
24/04/2008 Tygacil INN: tigecycline
19/03/2008 Evoltra INN: clofarabine
25/02/2008 Zavesca INN: Miglustat
28/01/2008 NutropinAq INN: somatropin
20/11/2007 Zometa INN:zoledronic acid
23/10/2006 Glivec INN: imatinib
13/10/2006 NovoNorm INN: repaglinide
13/10/2006 Prandin INN: repaglinide
30/06/2006 DepoCyte INN: cytarabine
02/05/2006 NovoSeven INN: eptacog alfa (activated)
23/02/2006 Opatanol INN: olopatadine hydrochloride
************
Medicinal products for which an application for other changes to the marketing authorisation was withdrawn
Withdrawal announced Medicinal product INN
20/11/08 Viagra INN: sildenafil
************
abrir aquí para acceder al documento general y desde allí a las moléculas de interés:
European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Background